Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Aug 30, 2024 | 50.79 | +0.59 |
NetScout Systems | NTCT | Aug 30, 2024 | 21.48 | +0.85 |
NETSOL Technologies | NTWK | Aug 30, 2024 | 2.70 | +1.89 |
Netstreit | NTST | Aug 30, 2024 | 16.69 | -0.30 |
Network-1 Technologies | NTIP | Aug 30, 2024 | 1.62 | +3.75 |
Neuberger Berman | NML | Aug 30, 2024 | 8.10 | -0.61 |
Neuberger Berman High Yield Strategies Fund | NHS | Aug 30, 2024 | 8.26 | -0.60 |
Neuberger Berman Municipal Fund | NBH | Aug 30, 2024 | 11.02 | -0.72 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Aug 30, 2024 | 12.44 | +0.81 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Aug 30, 2024 | 3.94 | +1.55 |
NeueHealth | NEUE | Aug 30, 2024 | 5.02 | +1.97 |
Neumora Therapeutics | NMRA | Aug 30, 2024 | 11.50 | +2.59 |
Neuraxis | NRXS | Aug 30, 2024 | 3.06 | -2.29 |
Neurobo Pharmaceuticals | NRBO | Aug 30, 2024 | 3.69 | +5.13 |
Neurocrine Biosciences | NBIX | Aug 30, 2024 | 127.06 | -1.07 |
Neurogene | NGNE | Aug 30, 2024 | 37.42 | +2.80 |
NeuroMetrix | NURO | Aug 30, 2024 | 3.82 | -1.56 |
Neuronetics | STIM | Aug 30, 2024 | 0.88 | +3.91 |
NeuroOne | NMTC | Aug 30, 2024 | 0.80 | -1.58 |
Neuropace | NPCE | Aug 30, 2024 | 7.92 | -0.38 |
NeuroSense Therapeutics | NRSN | Aug 30, 2024 | 0.89 | +17.11 |
Nevro | NVRO | Aug 30, 2024 | 6.19 | -2.37 |
New America High Income Fund | HYB | Aug 30, 2024 | 8.25 | -0.24 |
New Concept Energy | GBR | Aug 30, 2024 | 1.24 | -2.36 |
New England Realty Associates LP Unit A | NEN | Aug 30, 2024 | 80.25 | +0.99 |
New Fortress Energy A | NFE | Aug 30, 2024 | 12.32 | -0.48 |
New Found Gold | NFGC | Aug 30, 2024 | 2.68 | -1.83 |
New Germany Fund | GF | Aug 30, 2024 | 8.57 | +0.53 |
New Gold | NGD | Aug 30, 2024 | 2.51 | +0.80 |
New Horizon Aircraft | HOVR | Aug 30, 2024 | 0.99 | +4.55 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.